Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001019687-13-001707
Filing Date
2013-05-09
Accepted
2013-05-09 16:17:15
Documents
9
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q actc_10q-033113.htm 10-Q 452543
2 CERTIFICATION actc_ex3101.htm EX-31.1 7037
3 CERTIFICATION actc_ex3201.htm EX-32.1 2760
  Complete submission text file 0001019687-13-001707.txt   5105711

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE actc-20130331.xml EX-101.INS 754748
5 XBRL SCHEMA FILE actc-20130331.xsd EX-101.SCH 59276
6 XBRL CALCULATION FILE actc-20130331_cal.xml EX-101.CAL 52971
7 XBRL DEFINITION FILE actc-20130331_def.xml EX-101.DEF 174417
8 XBRL LABEL FILE actc-20130331_lab.xml EX-101.LAB 407656
9 XBRL PRESENTATION FILE actc-20130331_pre.xml EX-101.PRE 273355
Mailing Address 33 LOCKE DRIVE MARLBOROUGH MA 01752
Business Address 33 LOCKE DRIVE MARLBOROUGH MA 01752 508-756-1212
ADVANCED CELL TECHNOLOGY, INC. (Filer) CIK: 0001140098 (see all company filings)

EIN.: 870656515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50295 | Film No.: 13829117
SIC: 2834 Pharmaceutical Preparations